ICD10 Disease Category |
Disease Name |
ICD10 Code |
Linked Targets |
G00-G99: Diseases of the nervous system G00-G99 |
Central nervous system disease |
G00-G99 |
CHRNA7; PPARD |
NA: NA |
Obstructive airway diseases |
NA |
SERPINA6 |
H00-H59: Diseases of the eye and adnexa |
Ocular inflammation |
H16.229 |
PPARG |
M00-M99: Diseases of the musculoskeletal system and connective tissue |
Gout |
M10 |
PPARG |
E00-E89: Endocrine, nutritional and metabolic diseases |
Metabolic disorders |
E70-E89 |
PPARD |
G00-G99: Diseases of the nervous system G00-G99 |
Mild to moderate alzheimer disease |
G30 |
CHRNA7 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Obesity |
E66 |
PTPN1; PPARD; PPARD; PPARG |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Cognitive disorders |
F01-F07, F04, F05, R41.3 |
CHRNA7 |
G00-G99: Diseases of the nervous system G00-G99 |
Parkinson's disease |
G20 |
CHRNA7 |
I00-I99: Diseases of the circulatory system |
Atherosclerosis |
I70 |
PPARD |
E00-E89: Endocrine, nutritional and metabolic diseases |
Diabetes |
E23.2, N25.1 |
PTPN1; PPARG |
N00-N99: Diseases of the genitourinary system |
Endometriosis |
N80 |
PPARG |
E00-E89: Endocrine, nutritional and metabolic diseases |
Dyslipidaemias |
E78 |
PPARD; PPARD |
E00-E89: Endocrine, nutritional and metabolic diseases |
Hyperlipidaemia |
E78 |
PPARD |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Attention deficit hyperactivity disorder |
F90 |
CHRNA7 |
NA: NA |
Dyslipidemia |
NA |
PPARD |
NA: NA |
Colour dead tissues |
NA |
PTPN1 |
A00-B99: Certain infectious and parasitic diseases |
Infections |
A00-B99 |
PTPN1 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Schizophrenia |
F20 |
CHRNA7; CHRNA7; CHRNA7 |
J00-J99: Diseases of the respiratory system |
Asthma |
J45 |
SERPINA6; CHRNA7 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Drug abuse |
F10-F19 |
PPARG |
K00-K95: Diseases of the digestive system |
Inflammatory bowel disease |
K50, K51 |
PPARG |
C00-D49: Neoplasms |
Inflammatory disease |
C11, C44, K75.9, M00-M25 |
SERPINA6 |
H00-H59: Diseases of the eye and adnexa |
Diabetic retinopathy |
H36, E10.3, E11.3, E13.3 |
SERPINA6 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Diabetic macular edema |
E08-E13, E08.3, E09.3, E10.3, E11.3, E13.3, H35.8, R60.9 |
SERPINA6 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Psychiatric disorder |
F01-F99 |
CHRNA7 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Type 1 diabetes |
E10 |
PPARD; PPARG |
E00-E89: Endocrine, nutritional and metabolic diseases |
Type 2 diabetes |
E11 |
PTPN1; PTPN1; PPARD; PPARG; PPARG |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Nicotine dependence |
F17 |
PPARG |
I00-I99: Diseases of the circulatory system |
Neurological disease |
I21, I22, R52, R52.1-R52.2, R60.9, G89 |
CHRNA7 |
R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified |
Anesthesia |
R20.0 |
CHRNA7 |
K00-K95: Diseases of the digestive system |
Non-alcoholic fatty liver disease |
K76.0 |
PPARD; PPARG |
G00-G99: Diseases of the nervous system G00-G99 |
Alzheimer disease |
G30 |
CHRNA7; CHRNA7; PPARG; PPARG |